• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 81 of 100
The Newly Refurbished Charles Dickens Museum Prepares To Open
HealthFemale Viagra Might Not Be All It’s Cracked Up To Be
By Robert HackettMarch 1, 2016
559537925
HealthWhy Shares of Diplomat Pharma Got Slammed Today
By Sy MukherjeeMarch 1, 2016
Roche's colon-cancer drug Avastin is displayed in a Cambridg
HealthThe US Throws Away $3 Billion Worth of Cancer Drugs A Year
By Laura LorenzettiMarch 1, 2016
Cancer research laboratory
HealthPharma’s Big New Cancer Drug May Be an Old Red Dye
By ReutersFebruary 26, 2016
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
FinanceIndian Companies Want to Sell U.S. Customers More Drugs
By Laura LorenzettiFebruary 25, 2016
An Initiative To Legalize Marijuana In California To Appear On Nov. Ballot
RetailCanada’s Biggest Drugstore Could Start Selling Medical Marijuana
By Tom Huddleston Jr.February 24, 2016
CVS - Most Admired 2016
HealthCVS Health Says Prescription Drug Spending Dropped Dramatically
By Laura LorenzettiFebruary 23, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
FinanceHere’s Why Valeant Shares Are Plunging Again
By ReutersFebruary 23, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
FinanceHere’s Why Shares of Valeant Have Plunged for Their Second Straight Day
By ReutersFebruary 22, 2016
Production At The Merck KGaA Pharmaceutical Plant
HealthChina suspends Ali Health-run online drug monitoring platform
By ReutersFebruary 21, 2016
UNITED STATES - FEBRUARY 04: Martin Shkreli, former CEO Turing Pharmaceuticals, invoked his Fifth Amendment right against self-incrimination during a House Oversight and Government Reform Committee in Rayburn Building on "methods and reasoning behind recent drug price increases," February 04, 2016. Turing had raised the price of Daraprim, used by AIDS and cancer patients, from $13.50 to $750 a pill. (Photo By Tom Williams/CQ Roll Call)
LeadershipSeveral Witnesses in the Martin Shkreli Case Are Worried About Retaliation
By ReutersFebruary 19, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthThese Philanthropists Just Gave $7.2 Million to Solve the Drug Price Crisis
By Laura LorenzettiFebruary 17, 2016
Daily Antiretroviral Pill Found To Protect Healthy From AIDS Transmission
HealthExpress Scripts Won’t Air ‘Dirty Laundry’ In Heated Anthem Dispute
By Laura LorenzettiFebruary 17, 2016
AstraZeneca Plc Is Tougher Pfizer Inc. Target as Possible Bid Looms
HealthSome Popular Heartburn Drugs Have Been Linked to Dementia
By Claire GrodenFebruary 16, 2016
Donald Trump Campaigns In New Hampshire Ahead Of Primary
HealthTrump Somehow Plans to Negotiate Drug Prices to Zero
By Laura LorenzettiFebruary 12, 2016
1...
  • 79
  • 80
  • 81
  • 82
  • 83
...100
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.